Names | |
---|---|
Other names
KLB
| |
Identifiers | |
3D model (JSmol)
|
|
PubChem CID
|
|
| |
| |
Properties | |
C76H107N27O30S3 | |
Molar mass | 1975.03 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Klebsazolicin (KLB) is a peptide antibiotic encoded in the genome of a gram-negative bacterium Klebsiella pneumoniae subsp. ozonae and targeting prokaryotic ribosome.[1][2] Klebsazolicin is a ribosomally synthesized and post-translationally modified peptide (RiPP) and a linear azol(in)e-containing peptide (LAP).